Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

15 Nov 2017 15:38

RNS Number : 6213W
Impellam Group plc
15 November 2017
 

 

Impellam Group plc

(''Impellam'' or the ''Company'')

Trading update

 

Impellam plc, a leading provider of managed services and specialist staffing expertise, issues the following trading update prior to entering its close period for its full year results for the 52 weeks ending 29th December 2017.

 

Trading performance

 

Notwithstanding the ongoing disruption in the UK healthcare market and generally challenging trading conditions in the UK including Brexit uncertainty, pay rate stagnation and increased cost of compliance, whilst EBITDA is likely to be slightly below market expectations the Board is pleased to confirm that it expects to deliver 2017 pre-tax profits in line with market expectations.

 

 Younifi, our new business that provides a full-service solution to help councils better manage, fund and provide adult social care services, continues to gain momentum and has just reached a major milestone. In October 2017 and following a competitive tender, Younifi became the sole supplier on a new and highly innovative national framework called Managing Care Solutions, led by the procurement specialist YPO. The framework provides an easier route for all UK local authorities, who collectively spend over £21bn per year on adult social care, to purchase Younifi's solution and there has already been clear intent from the first local authority to adopt Younifi.

 

Good progress is being made in the achievement of our strategic initiatives including new technological solutions in the UK and Australia Healthcare markets which has resulted in 9 wins in H2. Amongst these wins is our first Staffbank contract which is an important milestone as we evolve our service offering to closely align to NHS strategic objectives.

Our Group Fill initiative continues to yield results with progress in North America being particularly noteworthy since the acquisition of Bartech, leading to staffing margin gains from US Managed Service programmes, which together with new implementations have partially offset the impact of delayed 2016 implementations.

 Our Australian businesses continue to perform very well in Healthcare, Managed Services and Specialist Staffing. After seven years' service The Honourable Shane Stone has notified the Company of his intention to step down from the Board with immediate effect, in order to concentrate on his charitable interests in Australia, however the Board is pleased to confirm that he will continue to serve as an advisor to the Company in its Australian markets.

In light of the challenging market conditions in the UK, we have been managing the business prudently and as a result we have 110 (3%) fewer people than at the end of June 2017. Cash generation continues to be strong and we expect net debt to be lower (circa ÂŁ89m) than at the end of 2016 (31 December 2016: ÂŁ95.2m).

Outlook

 

Whilst the UK markets have been challenging, the Board remains confident that the Groups strategic initiatives, combined with both selective investment in growth opportunities and prudent cost management will deliver sustainable profit streams into 2018.

 

Enquiries:  For further information please contact the appropriate individual below:

 

Impellam Group plc

Julia Robertson, Group Chief Executive Officer

Alison Wilford, Chief Financial Officer

Tel: 01582 692658

Tel: 01582 692658

 

Cenkos Securities plc (NOMAD and Corporate Broker to Impellam)

Nicholas Wells

Mark Connelly

Tel: 020 7397 8900

 

Note to Editors:

Impellam Group plc, traded on the AIM (Symbol: IPEL) is a leading provider of Managed Services and Specialist Staffing expertise and is primarily based in the UK and North America, with smaller operations in Asia Pacific, Ireland and mainland Europe. Impellam Group plc provides fulfilling jobs at all levels, including doctors, lawyers, accountants, nurses, teachers, scientists, receptionists, drivers, chefs, administrators, engineers, technology specialists, cleaners, security guards, and manufacturing and warehouse operatives. Impellam Group plc is the 2nd largest staffing business in the UK and 6th largest MSP provider worldwide (as measured by Spend Under Management), employing over 3,400 people across 182 worldwide locations.

 

-END-

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEELFFDFFXFBQ
Date   Source Headline
22nd Nov 202311:40 amRNSForm 8.5 (EPT/RI)
22nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
21st Nov 20232:06 pmRNSForm 8.3 - Impellam Group Plc
21st Nov 202310:46 amRNSForm 8.5 (EPT/RI)
21st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
16th Nov 202311:46 amRNSForm 8.3 - Impellam Group PLC
16th Nov 202311:24 amRNSForm 8.5 (EPT/RI)
16th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Nov 20231:33 pmRNSForm 8.3 - Impellam Group Plc
15th Nov 20239:29 amRNSForm 8.5 (EPT/RI)
15th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Nov 202312:36 pmRNSForm 8.3 - Impellam Group Plc
14th Nov 202310:34 amRNSForm 8.5 (EPT/RI)
14th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
13th Nov 202311:51 amRNSForm 8.3 - Impellam Group Plc
13th Nov 202311:39 amRNSForm 8.5 (EPT/RI)
13th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th Nov 202312:16 pmRNSForm 8.3 - Impellam Group Plc
10th Nov 202310:37 amRNSForm 8.5 (EPT/RI)
10th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th Nov 202311:45 amRNSForm 8.3 - Impellam Group PLC
8th Nov 20235:46 pmRNSPUSU Extension and Interim Dividend
8th Nov 20234:07 pmRNSExtension of PUSU Deadline
8th Nov 20232:04 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202312:29 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202311:02 amRNSForm 8.5 (EPT/RI)
7th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
6th Nov 202310:45 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 202311:18 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 20239:22 amRNSForm 8.5 (EPT/RI)
3rd Nov 20237:05 amRNSTransaction in Own Shares & Rule 2.9 Announcement
2nd Nov 202312:09 pmRNSForm 8.3 - Impellam Group PLC
2nd Nov 20239:57 amRNSForm 8.5 (EPT/RI)
2nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20232:21 pmRNSForm 8.3 - Impellam Group PLC
1st Nov 202310:30 amRNSForm 8.5 (EPT/RI)
1st Nov 20238:30 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
31st Oct 202311:28 amRNSForm 8.3 - Impellam Group PLC
30th Oct 202312:35 pmRNSForm 8.3 - Impellam Group PLC
26th Oct 202310:45 amRNSForm 8.5 (EPT/RI)
26th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
25th Oct 20233:41 pmRNSExtension of PUSU Deadline
25th Oct 202311:47 amRNSForm 8.5 (EPT/RI)
25th Oct 202311:17 amRNSForm 8.3 - Impellam Group plc
25th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Oct 202311:07 amRNSForm 8.5 (EPT/RI)
24th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Oct 202311:13 amRNSForm 8.5 (EPT/RI)
17th Oct 202311:38 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.